Objectives: Chronic dacryocystitis is usually seen in middle-aged or older women, suggesting that decreased estrogen and progesterone serum levels may be a causative factor in the disease pathology. However, the occurrence of the disease in premenopausal females and males suggests that there may be more to the explanation than the level of female sex hor-mones. The purpose of the present study was to investigate estrogen and progesterone receptor positivity in the lacrimal sacs of individuals with and without chronic dacryocystitis. Methods: The study group included 50 female and 20 male patients diagnosed with chronic dacryocystitis. Lacrimal sac samples were taken during a dacryocystorhinostomy. The control group comprised 29 cadavers with no evidence of lacrimal system pathology in the health records. The samples were obtained transconjunctivally. Lacrimal sac samples from both groups were stained with the estrogen and progesterone receptor protein antigen. Fisher's exact test and a chi-square test were used to compare the receptor positivity results of premenopausal and postmenopausal women, and samples of those with dacryocystitis and cadaver sacs without the disease. Results: In the control group, estrogen receptor positivity was observed in the samples of 2 premenopausal females. In the study group, estrogen receptor positivity was seen in 4 premenopausal females. There was no significant difference in estrogen receptor positivity between the premenopausal and postmenopausal female groups (p=0.41). A similar result was not established between the premenopausal and postmenopausal females in case group (p=0.056). No comparison was made of the progesterone receptor because only 1 example of progesterone receptor positivity was found in a pre-menopausal female in the dacryocystitis group. Conclusion: Estrogen receptor positivity did not seem to be a factor in chronic dacryocystitis physiopathology.
Yanoff M, Duker JS. Ophthalmology. 3rd ed. Philadelphia: Mosby Elsevier; 2009. p. 1482–7.
Bharathi MJ, Ramakrishnan R, Maneksha V, Shivakumar C, Nithya V, Mittal S. Comparative bacteriology of acute and chronic dacryocystitis. Eye (Lond) 2008;22:953–60.
Gilliland G. Dacryocystitis. In: Agarwal S, Agarwal A, Apple DJ, Buratto L, Alio JL, Pandey SK, et al., editors. Textbook of Oph-thalmology. Lippincott Williams &Wilkins; 2002. p.705.
Alnawaiseh M, Mihailovic N, Wieneke AC, Prokosch V, Rosen-treter A, Merté RL, et al. Long-Term Outcomes of External Dacryocystorhinostomy in the Age of Transcanalicular Mi-croendoscopic Techniques. J Ophthalmol 2016;2016:5918457.
Bartley GB. Acquired lacrimal drainage obstruction: an etiologic classification system, case reports, and a review of the litera-ture. Part 1. Ophthalmic Plast Reconstr Surg 1992;8:237–42.
Majidaee M, Mohammadi M, Sheikh MR, Khademlu M, Gorji MH. Patients undergoing dacryocystorhinostomy surgery in northern iran: an epidemiologic study. Ann Med Health Sci Res 2014;4:365–8.
Mauriello JA Jr, Palydowycz S, DeLuca J. Clinicopathologic study of lacrimal sac and nasal mucosa in 44 patients with complete acquired nasolacrimal duct obstruction. Ophthalmic Plast Re-constr Surg 1992;8:13–21.
Tucker N, Chow D, Stockl F, Codère F, Burnier M. Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients. Ophthalmology 1997;104:1882–6.
Mito H, Takahashi Y, Nakano T, Asamoto K, Ikeda H, Kakizaki H. Consecutive microscopic anatomical characteristics of the lacrimal sac and nasolacrimal duct: cases with or without in-flammation. Invest Ophthalmol Vis Sci 2014;55:5233–7.
Orbit, Eyelids, and Lacrimal System. Singapore: American Academy of Ophthalmology; 2011.
Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992;73:570–4.
Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995;13:217–26.
Buggage RR, Matteson DM, Shen DF, Sun B, Tuaillon N, Chan CC. Effect of sex hormones on experimental autoimmune uve-oretinitis (EAU). Immunol Invest 2003;32:259–73.
Paridaens DA, Alexander RA, Hungerford JL, McCartney AC. Oestrogen receptors in conjunctival malignant melanoma: im-munocytochemical study using formalin fixed paraffin wax sec-tions. J Clin Pathol 1991;44:840–3.
Roussos J, Bouzas A. Attempted explanation with hormonal factors of the greater occurrence of chronic dacryocystitis in women than in men. [Article in French]. Bull Mem Soc Fr Oph-talmol 1973;86:96–9.
Wickham LA, Rocha EM, Gao J, Krenzer KL, da Silveira LA, Toda I, et al. Identification and hormonal control of sex steroid receptors in the eye. Adv Exp Med Biol 1998;438:95–100.
Molteni A, Warpeha RL, Brizio-Molteni L, Fors EM. Estradiol receptor-binding protein in head and neck neoplastic and nor-mal tissue. Arch Surg 1981;116:207–10.
Gupta A, Prabhakaran VC, Dodd T, Selva D. Characterization of lacrimal sac histology: an immunohistochemical study. Clin Exp Ophthalmol 2012;40:869–73.